ClinicalTrials.gg
RecruitingNCT07552766Updated Jul 6, 2026

A Clinical Trial on the Use of Lidocaine Infusion During Surgery for Pediatric Upper Extremity Fractures and Its Impact on Total Perioperative Opioid Requirements

A Phase 4 interventional study of Lidocaine Infusion and Standard of Care (SOC) in Fracture Arm, Fracture Closed of Lower End of Forearm, Unspecified and Fracture Elbow, sponsored by Nemours Children's Clinic. Recruiting at 1 site in United States. Open to participants aged 3 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-07-06.

Sponsored by Nemours Children's Clinic · Phase 4, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jun 2026; still recruiting 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 4
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
3 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 17 studies in Elbow Fractures with a site in United States — 7 open to participants now, 7 under way, none of them phase 3. Elbow Fractures · United States.

Planned enrollment
6th of 14
90 · median 85
Started
2026
with 3 others
Phase 4
3 of 17
2 open now
Registered
15th of 17
by date
Lead sponsor
2 of 17
Nemours Children's Clinic

Among the 17 studies in Elbow Fractures with a site in United States, this one is the 6th largest by planned enrollment of the 14 interventional ones that give a count, is one of 4 that started in 2026, is one of 3 in phase 4, and was the 15th registered.

Elbow Fractures

48 studies on the registry are indexed under Elbow Fractures; 14 are open to participants now.

Browse Elbow Fractures studies →

Open to participants now

7 of the 17 studies in Elbow Fractures with a site in United States are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 10 Elbow Fractures studies recruiting now, 2 (20%) set no upper age limit and 8 (80%) stop at 75 or younger; 8 take children under 18; 3 take healthy volunteers.

This study: 3 Years to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 17 studies in Elbow Fractures with a site in United States, or all of them as a file.
02

Study summary

This study is a prospective, randomized, double-blind clinical trial evaluating whether intraoperative intravenous lidocaine infusion (IVLI) reduces opioid requirements and improves postoperative pain control in children undergoing surgical fixation of upper extremity long bone fractures under general anesthesia. Ninety pediatric patients, ages 3-18 will be enrolled and randomized 1:1 to receive either IV lidocaine or placebo (normal saline) during surgery.

All participants will receive standardized anesthesia care and postoperative pain management. Opioid consumption and pain scores will be measured intraoperatively and throughout the postoperative recovery, with the primary outcome focused on total opioid use 60 minutes after arrival to the post-anesthesia care unit (PACU). Secondary outcomes include opioid use at additional time points, postoperative pain scores, PACU length of stay, rescue antiemetic use and the relationship between infusion duration and outcomes.

Patients will be closely monitored for signs of local anesthetic systemic toxicity and other adverse events. The goal of this study is to determine whether IV lidocaine is an effective opioid-sparing adjunct in pediatric orthopedic surgery and to support safer, multimodal analgesia strategies.

03

Conditions studied

  • Fracture Arm
  • Fracture Closed of Lower End of Forearm, Unspecified
  • Fracture Elbow
  • Fracture Fixation
  • Fracture Fixation, Internal
  • Fracture Forearm
  • Fracture Distal Radius
04

Who can participate

Ages eligible
3 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 3-18 years
  • Patients > 10 kg
  • Patients who present to Nemours Children's Hospital - Delaware Valley (NCH-DE) for surgical fixation of upper extremity fractures from distal humerus to distal radius

Exclusion criteria

Exclusion Criteria:

  • Children \< 3 years or > 18 years
  • Patients with allergy to local anesthetics
  • Patients who are eligible for an receive a peripheral nerve block
  • Patients with multi-trauma or open fractures
  • Patients with previous history of seizure disorder
  • Patients with conduction abnormalities or cardiac arrhythmia requiring chronic treatment
  • Patients on strong CYP450 inhibitors (fluvoxamine, erythromycin, ciprofloxacin, rifampin, allopurinol, ketoconazole, itraconazole)
  • Patients with chronic kidney or liver dysfunction
  • Patients with planned use of continuous infusion pain medications (opioids, ketamine, alpha-2- agonists)
  • Patients with positive pregnancy test prior to surgery or nursing mothers
  • Patients who parents decline enrollment
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
90 participants (estimated)

Study arms

  • Experimental
    Patients receiving lidocaine infusion

    Drug: Lidocaine Infusion

  • Placebo comparator
    Patients receiving placebo

    Other: Standard of Care (SOC)

Interventions

  • DrugLidocaineStudies of LidocaineLidocaine pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Patients will be randomized to receive either lidocaine infusion or placebo intraoperatively. Perioperative opioid requirements will be compared between the two groups.

  • OtherStandard of Care (SOC)

    Standard of care

06

What researchers measure

Primary outcomes

  1. Total perioperative opioid consumption

    Determine the effect of IVLI on intraoperative and postoperative opioid consumption in pediatric patients undergoing orthopedic surgery for long bone fractures of the upper extremity

    Time frame: 60 minutes after patient arrival to post-anesthesia care unit (PACU)

Secondary outcomes

  1. Postoperative pain scores

    The maximum postoperative pain scores in patients who received IVLI will be equivalent or less than patients who received placebo in PACU at 30, 60, and 90 minutes and the time when patient meets Phase 1 PACU discharge criteria.

    Time frame: 30, 60, 90 minutes and the time when patient meets Phase 1 PACU discharge criteria.

  2. Rescue Anti-Emetic Use

    Assess the effect of IVLI on rescue anti-emetic use and Phase 1 PACU length of stay.

    Time frame: Duration of Phase 1 PACU length of stay

  3. Infusion and Surgical Length

    Evaluate if the infusion time of IVLI impacts post-operative opioid consumption and post- operative pain scores. Hypothesis: Patients who receive IVLI for \> 2 hours will have lower post- operative opioid requirements and post-operative pain scores than patients who receive the infusion for \< 2 hours.

    Time frame: 60 minutes after patient arrives in post-anesthesia care unit (PACU)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Heath C, Hii J, Thalayasingam P, von Ungern-Sternberg BS, Sommerfield D. Perioperative intravenous lidocaine use in children. Paediatr Anaesth. 2023 May;33(5):336-346. doi: 10.1111/pan.14608. Epub 2022 Dec 4. PubMed 36424875 ↗
  • Pardessus P, Loiselle M, Brouns K, Horlin AL, Bruneau B, Maroun Y, Lagarde M, Deliere M, Julien-Marsollier F, Dahmani S. Intravenous lidocaine for postoperative analgesia management in paediatrics: A systematic review with meta-analysis of published studies. Eur J Anaesthesiol. 2024 Nov 1;41(11):856-864. doi: 10.1097/EJA.0000000000002046. Epub 2024 Jul 29. PubMed 39076006 ↗
  • Gupta A, Ashok V. Perioperative intravenous lignocaine for pediatric postoperative pain-A systematic review and meta-analysis. Paediatr Anaesth. 2025 Jan;35(1):25-32. doi: 10.1111/pan.15015. Epub 2024 Oct 4. PubMed 39365287 ↗
  • Kaszynski M, Lewandowska D, Sawicki P, Wojcieszak P, Pagowska-Klimek I. Efficacy of intravenous lidocaine infusions for pain relief in children undergoing laparoscopic appendectomy: a randomized controlled trial. BMC Anesthesiol. 2021 Jan 5;21(1):2. doi: 10.1186/s12871-020-01218-0. PubMed 33397287 ↗
  • Hall EA, Sauer HE, Davis MS, Anghelescu DL. Lidocaine Infusions for Pain Management in Pediatrics. Paediatr Drugs. 2021 Jul;23(4):349-359. doi: 10.1007/s40272-021-00454-2. Epub 2021 May 26. PubMed 34036532 ↗
  • Chu R, Umukoro N, Greer T, Roberts J, Adekoya P, Odonkor CA, Hagedorn JM, Olatoye D, Urits I, Orhurhu MS, Umukoro P, Viswanath O, Hasoon J, Kaye AD, Orhurhu V. Intravenous Lidocaine Infusion for the Management of Early Postoperative Pain: A Comprehensive Review of Controlled Trials. Psychopharmacol Bull. 2020 Oct 15;50(4 Suppl 1):216-259. doi: 10.64719/pb.4391. PubMed 33633427 ↗
  • Finholt DA, Stirt JA, DiFazio CA, Moscicki JC. Lidocaine pharmacokinetics in children during general anesthesia. Anesth Analg. 1986 Mar;65(3):279-82. PubMed 3954094 ↗
  • Mazoit JX, Dalens BJ. Pharmacokinetics of local anaesthetics in infants and children. Clin Pharmacokinet. 2004;43(1):17-32. doi: 10.2165/00003088-200443010-00002. PubMed 14715049 ↗
  • Foong KW, Loh PS, Chaw SH, Lo YL. Population Pharmacokinetics of IV Lidocaine and its Metabolites in Adult Surgical Patients. Pharm Res. 2025 Mar;42(3):451-473. doi: 10.1007/s11095-025-03835-1. Epub 2025 Feb 28. PubMed 40021547 ↗
  • Ochs HR, Knuchel M, Abernethy DR, Greenblatt DJ. Dose-independent pharmacokinetics of intravenous lidocaine in humans. J Clin Pharmacol. 1983 Apr;23(4):186-8. doi: 10.1002/j.1552-4604.1983.tb02723.x. No abstract available. PubMed 6863582 ↗
  • Weibel S, Jokinen J, Pace NL, Schnabel A, Hollmann MW, Hahnenkamp K, Eberhart LH, Poepping DM, Afshari A, Kranke P. Efficacy and safety of intravenous lidocaine for postoperative analgesia and recovery after surgery: a systematic review with trial sequential analysis. Br J Anaesth. 2016 Jun;116(6):770-83. doi: 10.1093/bja/aew101. PubMed 27199310 ↗
  • Keil LG, Sullivan MH, Dadoo S, Stillwagon MR, Vergun AD. How Much Opioid Do Kids Actually Need? A Prospective Study of Analgesic Prescribing and Postdischarge Opioid Use Among Pediatric Patients With Operative Fractures. J Pediatr Orthop. 2021 Nov-Dec 01;41(10):e871-e876. doi: 10.1097/BPO.0000000000001965. PubMed 34516466 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2026 (actual). Primary completion is estimated for Dec 2028, 30 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 2, 2026
First posted
Apr 27, 2026
StartActual
Jun 24, 2026
Primary completionEst.
Dec 2028
CompletionEst.
Jul 2029
Last update
Jul 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07552766
Responsible party
Angela Snow (Pediatric Anesthesiologist, Nemours Children's Clinic) — Principal investigator
First posted
Apr 27, 2026
Start date
Jun 24, 2026
Primary completion
Dec 2028 (estimated)
Completion
Jul 2029 (estimated)
Last update
Jul 6, 2026

Study contacts

Angela Snow, MD
Contact
angela.snow@nemours.org
302-824-1792
Isabela Santiago, BS
Contact
isabela.santiago@nemours.org
302-577-0126

Oversight

Data monitoring committee
Yes
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Lidocaine

Start the discussion